ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,551Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 337

$595K Total Retail Price of All Prescriptions

Rank: 47 out of 337

632 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
7% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 632 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 632 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 12,791 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 828 803 1 1
LEVOTHYROXINE SODIUM 557 547 2 5
AMLODIPINE BESYLATE 482 465 3 3
LISINOPRIL 450 408 4 2
LOSARTAN POTASSIUM 429 425 5 15
OMEPRAZOLE 393 382 6 4
HYDROCHLOROTHIAZIDE 368 361 7 9
ATENOLOL 359 340 8 10
METOPROLOL SUCCINATE 353 339 9 21
ATORVASTATIN CALCIUM 350 325 10 7
METOPROLOL TARTRATE 290 279 11 6
FUROSEMIDE 254 247 12 8
METFORMIN HCL 203 156 13 12
QUINAPRIL HCL 189 184 14 50
CRESTOR 189 183 14 29
HYDROCODONE-ACETAMINOPHEN 169 167 S3 16 13
ZOLPIDEM TARTRATE 166 162 17 23
DILTIAZEM 24HR ER 140 140 18 76
TRIAMTERENE-HCTZ 136 136 19 39
PRAVASTATIN SODIUM 135 135 20 14
WARFARIN SODIUM 131 121 21 11
DIOVAN 118 118 22 26
ALENDRONATE SODIUM 117 117 23 19
CLOPIDOGREL 117 108 23 42
TAMSULOSIN HCL 113 101 25 25
DONEPEZIL HCL 111 111 26 22
ALLOPURINOL 111 111 26 28
PAROXETINE HCL 110 110 28 46
LIPITOR 108 106 29 33
SYNTHROID 105 105 30 41
SERTRALINE HCL 104 91 31 18
PREDNISONE 103 87 32 40
AMITRIPTYLINE HCL 102 76 R 33 75
GLYBURIDE 101 95 R 34 53
GABAPENTIN 100 95 35 20
CIPROFLOXACIN HCL 94 91 36 71
AZITHROMYCIN 90 84 37 51
MELOXICAM 88 88 38 54
ISOSORBIDE MONONITRATE ER 88 85 38 70
KLOR-CON M20 86 84 40 65
TRAZODONE HCL 84 75 41 16
PLAVIX 80 73 42 74
SPIRONOLACTONE 76 76 43 100
RANITIDINE HCL 74 66 44 30
CELEBREX 72 61 45 116
NEXIUM 71 59 46 56
POTASSIUM CHLORIDE 70 69 47 62
VERAPAMIL ER 70 59 47 77
CITALOPRAM HBR 68 63 49 17
DIGOXIN 67 67 50 58
LOVASTATIN 62 50 51 24
FLUOXETINE HCL 61 54 52 57
LOSARTAN-HYDROCHLOROTHIAZIDE 60 56 53 60
PROAIR HFA 58 50 54 38
LORAZEPAM 55 49 55 119
PROPRANOLOL HCL 55 55 55 121
INSULIN SYRINGE 54 54 57 127
PANTOPRAZOLE SODIUM 50 50 58 36
LABETALOL HCL 50 46 58 149
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 24, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.